发明名称 PHOSPHONATE PHARMACEUTICAL COMPOSITION
摘要 Diabetes mellitus in humans and animals, is treated by administering a carboxy phosphonate cpd. selected from carboxy vicinal phosphonates (I), dicarboxy monophosphonates (II) and carboxy geminal phosphonates (III). Cpds. I-III promote the metabolism of carbohydrates esp. glucose in humans and animals, and thus are useful for treating diabetes. They are administered in doses of 0.01-500 mg./kg., pref. 0.5-50 mg./kg. body wt. in a compsn. with a carrier. Typical cpds. are e.g. ethane-1,2-dicarboxy-1,2-diphosphonate and its sodium and pentasodium salts.
申请公布号 PH13895(A) 申请公布日期 1980.10.27
申请号 PH19900000210 申请日期 1978.05.02
申请人 PROCTER & GAMBLE CO 发明人 FLEISCH H;FELIX R
分类号 A61K31/66;A61P3/08 主分类号 A61K31/66
代理机构 代理人
主权项
地址